Cooley 2014.
Trial name or title | Title conference abstract: 'Point‐of‐care clinical decision support for cancer symptom management: results of a group randomized trial' |
Methods | RCT ‐ with intervention group (IG) and control group (CG) |
Participants | Cancer patients (no further specification in conference abstract) Country: USA Age: mean age of 63 years Sex: 58% female Inclusion criteria: unclear Exclusion criteria: unclear N randomised: n = 179, number of participants in each condition unclear. N in analysis: unclear |
Interventions |
Content of screen:BIO‐PSYCHOSOCIAL WELL‐BEING: The symptom assessment resulted in insight on participants’ pain, fatigue, depression, anxiety, and/or dyspnoea Interventionist: Presumably use of a self‐completion tool, no interventionist for the screening act (“patients completed the web based symptom assessment”) Intervention procedure:SI with co‐intervention to use screening results: Participants completed the symptom assessment prior to each visit for 6 months. A tailored report provided a longitudinal symptom report, and suggestions for management were provided to clinicians in the SAMI arm prior to the visit. Conditions for implementation
Comparative condition: usual care condition Length of follow‐up: 6 months |
Outcomes |
Primary outcomes
Secondary outcomes: management of the target symptoms (chart review) Outcome time points: baseline; 2, 4, and 6 months |
Starting date | Unclear |
Contact information | First author conference abstract: Prof Dr Mary E Cooley, Dana‐Farber/Harvard Cancer Institute, Boston |
Notes | Information from conference abstract available, no further information received from study authors. Results paper in preparation |